Topic: contract manufacturer
GlaxoSmithKline will unload an API plant to Thermo Fisher Scientific for €90 million. The U.S. company says it is glad to get it.
The possible cross-contamination with peanut flour of Novartis' anemia drug Promacta occurred at a contract manufacturing site.
After manufacturing issues led ADMA Biologics to pull its primary immune deficiency disease drug Bivigam from the market, it's won a new FDA approval.
Ireland-based Nabriva had one of its new antibiotics rejected by the FDA because of problems with a contract manufacturer in Europe.
A contractor has opened a new plant in Iran to make meds for Merck KGaA exclusively with a capacity of up to 7 billion solid doses.
Sun Pharma has been issued a Form 483, Catalent is investing $14 million at a facility in Germany and more manufacturing news of note.
A Lithuanian CDMO is investing €50 million in its biologics manufacturing site and adding up to 80 jobs.
Chinese CDMO GenScript Biotech has started construction on a production facility to specialize in plasmids and viruses manufacturing.
Ajinomoto Bio-Pharma Services has concluded a deal that will allow the CDMO to operate in the gene therapy space.
CDMOs Cambrex and Ajinomoto Bio-Pharma Services upgraded manufacturing plants, Takeda scored an albumin approval via its Shire deal, and more.